Your browser doesn't support javascript.
loading
Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
Lee, Sang Eun; Kim, Yong-Jin; Lee, Hae-Young; Yang, Han-Mo; Park, Chang-Gyu; Kim, Jae-Joong; Kim, Soon-Kil; Rhee, Moo-Yong; Oh, Byung-Hee.
Affiliation
  • Lee SE; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.
Clin Ther ; 34(3): 552-568, 568.e1-9, 2012 Mar.
Article in En | MEDLINE | ID: mdl-22381711
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Tetrazoles / Biphenyl Compounds / Losartan / Angiotensin Receptor Antagonists / Hypertension / Antihypertensive Agents Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Country/Region as subject: Asia Language: En Journal: Clin Ther Year: 2012 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Tetrazoles / Biphenyl Compounds / Losartan / Angiotensin Receptor Antagonists / Hypertension / Antihypertensive Agents Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Country/Region as subject: Asia Language: En Journal: Clin Ther Year: 2012 Document type: Article